A possible case of myelopathy/tropical spastic paraparesis in an Argentinian woman with human T lymphocyte virus type II

Clinical Infectious Diseases

Volumn 37, Issue 3, 2003, Pages 456-458

  Biglione, Mirna M ^a   Pizarro, Manuel ^b   Salomón, Horacio E ^a   Berría, María I ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Hospital Pablo Soria   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARGENTINA; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN T LYMPHOCYTE VIRUS TYPE 2; LABORATORY TEST; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; T LYMPHOCYTE; VIRUS; WESTERN BLOTTING;

ADULT; ARGENTINA; FEMALE; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; PARAPARESIS, TROPICAL SPASTIC;

EID: 0042160241     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/376620     Document Type: Article

References (26)

1. Tortora CC, Quincoces V, Dipierri JE. Seroepidemiology of Chagas disease in the province of Jujuy [in Spanish]. Medicina (B Aires) 1996; 56:383-8.
2. Genovese O, Ballario C, Storino R, et al. Clinical manifestations of peripheral nervous system involvement in human chronic Chagas disease. Arq Neuropsiquiatr 1996; 54:190-6.
3. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2:407-10.
4. McKhann G 2nd, Gibbs CJ Jr, Mora CA, et al. Isolation and characterization of HTLV-I from symptomatic family members with tropical spastic paraparesis (HTLV-I encephalomyeloneuropathy). J Infect Dis 1989; 160:371-9.
5. Castro-Costa CM, Cartón H, Santos TJ. HTLV-I negative tropical spastic paraparesis: a scientific challenge. Arq Neuropsiquiatr 2001; 59:289-94.
6. Daenke S, Parker CE, Niewiesk S, et al. Spastic paraparesis in a patient carrying defective human T cell leukemia virus type I (HTLV-I) provirus sequences but lacking a humoral or cytotoxic T cell response to HTLV-I. J Infect Dis 1994; 169:941-3.
7. Berger JR, Svenningsson A, Raffanti S, et.al. Tropical spastic paraparesis-like illness occurring in a patient dually infected with HIV-I and HTLV-II. Neurology 1991; 41:85-7.
8. Kira JI, Koyanagi Y, Hamakado T, et al. HTLV-II in patients with HTLV-I-associated myelopathy. Lancet 1991; 338:64-5.
9. Hjelle B, Appenzeller O, Mills R, et al. Chronic neuro-degenerative disease associated with HTLV-II infection. Lancet 1992; 339:645-6.
10. Harrington W Jr, Sheremata W, Hjelle B, et al. Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Ann Neurol 1993; 33:411-4.
11. Jacobson S, Lehky T, Nishimura M, et al. Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I associated myelopathy/tropical spastic paraparesis. Ann Neurol 1993; 33:392-6.
12. Sheremata W, Jr Harrington WJ, Bradshaw P, et al. Association of (tropical) ataxic neuropathy with HTLV-II. Virus Res 1993; 29:71-7.
13. Black F, Biggar RJ, Lal R, et al. Twenty-five years of HTLV type II follow-up with a possible case of tropical spastic paraparesis in the Kayapo, a Brazilian indian tribe. AIDS Res Hum Retroviruses 1996; 12:1623-7.
14. Murphy EL, Glynn SA, Fridey J, et al. Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I- infected blood donors. Arch Intern Med 1999; 159:1485-91.
15. Silva EA, Otsuki K, Leite AC, et al. HTLV-II infection associated with a chronic neurodegenerative disease: clinical and molecular analysis. J Med Virol 2002; 66:253-7.
16. Fujiyoshi, T, Li HC, Lou H, et al. Characteristic distribution of HTLV type I and HTLV type II among native ethnic groups in South America. AIDS Res Hum Retroviruses 1999; 20:1235-9.
17. Biglione M, Pizarro M, Martínez Peralta L, et al. High prevalence of HTLV-I infection in Argentinean blood donors: a new HTLV-I endemic area? J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:101-2.
18. Dipierri JE, Tajima K, Cartier Robirosa L, et al. A seroepidemiological survey of HTLV-I/II carriers in the Puna Jujeña. Medicina (B Aires) 1999; 59:717-20.
19. Biglione M, Gessain A, Quiruelas S et al. Endemic HTLV-II infection among Toba and Mataco Amerindians from north Argentina. J Acquir Immune Defic Syndr 1993; 6:631-2.
20. Bouzas MB, Zapiola I, Quiruelas S, et al. HTLV type I and HTLV type II infection among Indians and natives from Argentina. AIDS Res Hum Retroviruses 1994; 10:1567-71.
21. Ferrer J, Del Pino N, Esteban E et al. High rate of infection with the human T-cell leukemia retrovirus type II in four Indian populations of Argentina. Virology 1993; 197:576-84.
22. Biglione MM, Pizarro M, Puca A, et al. A cluster of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jujuy (Argentina). J Acquir Immune Defic Syndr 2003; 32:441-5.
23. Goubau P, Carton H, Kazadi K, et al. HTLV seroepidemiology in a central African population with high incidence of tropical spastic paraparesis. Trans R Soc Trop Med Hyg 1990; 84:577-9.
24. Kayembe K, Goubau P, Desmyter I, et al. A cluster of HTLV-I associated tropical spastic paraparesis in Equateur (Zaire): ethnic and familial distribution. J Neurol Neurosurg Psychiatry 1990; 53:4-10.
25. Renjifo B, Osterman J, Borrero I, et al. Nucleotide sequences of human T-lymphotropic virus type I (HTLV-I) from a family cluster with tropical spastic paraparesis/HTLV-I associated myelopathy. Res Virol 1995; 146:93-9.
26. Biglione M, Vidan O, Mahieux R, et al. Seroepidemiological and molecular studies of human T-cell lymphotopic virus type 2, subtype B, in isolated groups of Mataco and Toba Indians of northern Argentina. AIDS Res Hum Retroviruses 1999; 15:407-17.